Oricula Therapeutics LLC — Form D
Oricula Therapeutics LLC of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-21. The offering totals $450K, of which $45K was reported sold. Industry: Other.
Offering
- Filed: 2015-01-21
- Form: D
- Accession: 0001590934-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $450K
- Amount sold: $45K
- Remaining: $405K
- Investors: 1
- Date of first sale: 2015-01-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232649
Issuer
- Name: Oricula Therapeutics LLC
- CIK: 0001590934
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 474 39TH AVENUE EAST, SEATTLE, WA, 98112
- Phone: 206-322-7526
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Ed Rubel | Director | Seattle, WA |
| Ed Rubel | Promoter | Seattle, WA |
| Vince Groppi | Director | Seattle, WA |
| Vince Groppi | Promoter | Seattle, WA |
| Malcolm Gleser | Director | Seattle, WA |
| Malcolm Gleser | Executive Officer | Seattle, WA |
| Malcolm Gleser | Promoter | Seattle, WA |
Other filings by this issuer (4)
More